Uni-Bio Science 2023 Interim Results，Achieved Record High Profit of HK$39.4M，Driven by Scale-Up Operations and Remarkable Growth in Marketed Drugs，Expanding Multiple Channels and Diverse Commercialization for New Products
Uni-Bio Science Announces 2022 Annual Results，Record High Turnover of HK$440.3 Million and HK$38.5 Million Profit Achieved Expanding Portfolio with New Drug Innovations and Strategic R&D Partnerships
From February 23, Uni-Bio Science Group's 2023 Annual Strategy Conference was held in Beijing, attended by the Chairman, CEO, heads and colleagues of the BU.
From February 15 to 17, Uni-Bio Science Group's 2023 Annual Marketing Conference was held in Xiamen, attended by the Chairman and CEO of Uni-Bio and all front-line marketing backbones from all units across the country. Embarking on a new journey, many new
[HONG KONG, February 16, 2023] Recently, Inaugural Hong Kong Innopreneur Award Presentation Ceremony was successfully held in Hong Kong.